2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Wednesday, September 25, 2019

1:15pm-2:45pm: Strategies to minimize complications in deep brain stimulation in a series of 240 DBS procedures

C.. Matthies, R.. Nickl, P.. Capetian, J.. Volkmann, R-I. Ernestus, P. Fricke (Wuerzburg, Germany)

Surgical Therapy · Les Muses Terrace, Level 3

1:15pm-2:45pm: Structural and functional MRI brain alterations of Lewy body diseases

O. Lucas-Jiménez, N. Ibarretxe-Bilbao, N. Ojeda, J. Peña, A. Cabrera-Zubizarreta, A. Murueta-Goyena, JC. Gómez-Esteban, I. Gabilondo (Bilbao, Spain)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: Structural changes in non-manifesting GBA mutation carriers and GBA mutation carriers with Parkinson’s disease

T. Yousaf, M. Kershaw, V. Suarez Contreras, P. Vickers, G. Pagano, M. Politis (London, United Kingdom)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: Structural connectivity changes in G2019S-LRRK2 gene mutation carriers without manifest Parkinson’s disease

G. Pagano, P. Vickers, J. Schulz, H. Wilson, M. Politis (London, United Kingdom)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: Structural connectome of brainstem nuclei in REM sleep behavior disorder, a model of premanifest synucleinopathy

MG. García-Gomar, LD. Lewis, L. Wald, B. Rosen, A. Videnovic, M. Bianciardi (Boston, MA, USA)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: Structural imaging changes in hepatic and neurological Wilson disease

A. Patel, K. Nalamada, A. Vives-Rodriguez, D. Robakis, T. Constable, J. Arora, M. Schilsky, S. Tinaz (New Haven, CT, USA)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: Study of Epidemiological Risk Factors in a Male-Only North Indian Parkinson’s Cohort

K. Shukla, N. Sawal (Chandigarh, India)

Epidemiology · Les Muses, Level 3

1:15pm-2:45pm: Subacute Encephalopathy with Pimavanserin Treatment in Parkinson Disease

J. King, G. Volkell, J. Wyant, E. Molho (Albany, NY, USA)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: Substantia Nigra (SN) Hyperechogenicity as seen in Transcranial Sonography (TCS) is a reliable disease progression marker from Stage I to Stage II in Early Onset Parkinson’s Disease (EOPD)

S. Ravi, V. Shivkumar, D. Dang, T. Gilmour, A. Espay, J. Wang, T. Subramanian, K. Venkiteswaran (Hershey, PA, USA)

Phenomenology and Clinical Assessment of Movement Disorders · Les Muses Terrace, Level 3

1:15pm-2:45pm: Successful treatment of secondary dystonia with deep brain stimulation of the globus pallidus internus

S. Hendrickx, PH. Bourgeois, A. Tieleman, D. Vanhauwaert, T. Couvreur, O. van Damme (Roeselare, Belgium)

Surgical Therapy · Les Muses Terrace, Level 3